Who owns IRLA?
Institutional ownership of IRulya Therapeutics Inc. from Form 13F, Q2 2026
27 institutional managers reported holding IRulya Therapeutics Inc. (IRLA) in Form 13F filings for Q2 2026, with 330,062 shares worth $6.0M. The largest reported holder was Ikarian Capital, LLC. 27 opened new positions and 0 sold out.
- Funds holding
- 27
- Value held
- $6.0M
- New / sold out
- 27 / 0
- Net shares, same filers
- None
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of IRLA
Share of 13F holdings is each fund's shares as a share of the 330,062 IRLA shares all 13F filers reported, not of shares outstanding.
Questions about IRLA ownership
- Who owns IRLA stock?
- 27 institutional investment managers reported IRLA positions in their Form 13F filings for Q2 2026, holding 330,062 shares worth $6.0M in total. Ikarian Capital, LLC reported the largest position.
- Are funds buying or selling IRLA?
- 27 managers opened new IRLA positions in Q2 2026.
- How current is this IRLA institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to IRLA by CUSIP. Options are left out. IRLA news and filings · IRLA insider trades · Top funds